In a brief filed Sep 1 in its case demanding that the U.S. Food and Drug Administration (FDA) release the hydroxychloroquine (HCQ) in the Strategic National Stockpile (SNS) for public use, the Association of American Physicians & Surgeons (AAPS) writes:
AAPS asserts in its brief that FDA has tacitly conceded that:
- “the HCQ stockpile contains 60 million doses donated for the purpose of treating COVID-19”;
- “experts, including Yale Professor Dr. Harvey Risch, observe that release of the HCQ Stockpile could save 50,000-100,000 American lives”;
- “HCQ has been approved as safe by the FDA and used safely since 1955, and the CDC officially declares HCQ to be safe today”;
- “foreign countries have kept their mortality rates far lower—sometimes 90% lower—than the United States’ rate, by encouraging use of HCQ”; and that
- “treating COVID-19, like treating the flu, requires taking medication as early as possible in the exposure to or progression of the disease.”
The FDA has argued that its decisions are not reviewable by a federal court. AAPS writes: “Under Defendants’ view they could dump the entire HCQ Stockpile into the Potomac River and there would be no legal accountability.”
WIND: I’ve said for years that the FDA’s job is to kill people by denying life-saving treatments and by imposing masssively costly bureaucracy, and (especially with big bucks involved e.g., statins) via outright corruption in league with Big Pharma (as in penalizing whistleblowers harshly, well documented fact). So this seems like pretty much standard operating procedure for the FDA.
But is HCQ life-saving or not? The preponderance of evidence looks increasingly against that notion. Yet if there is a 30% chance it works for a good chunk of patients using the right protocol, it is premature to shut off the possibility. Real science is never settled, and anyone who has certainty on such things is not qualified to discuss it.